SCHEDULE: Todd Hale Morrison Reports Zero Stake in BioRestorative Therapies

Todd Hale Morrison has filed an Amendment No. 8 to Schedule 13G, reporting zero beneficial ownership in BioRestorative Therapies, Inc. as of February 23, 2026.

Summary

• Todd Hale Morrison, an individual, filed an Amendment No. 8 to Schedule 13G concerning BioRestorative Therapies, Inc.'s Common Stock.
• As of February 23, 2026, Todd Hale Morrison beneficially owned 0 shares of BioRestorative Therapies, Inc.'s common stock.
• This represents 0.0% of the outstanding shares of the issuer.
• The reporting person holds no sole or shared voting power, nor sole or shared dispositive power over these securities.
• The securities were not acquired or held for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative signal, as a reporting person has fully divested their stake in BioRestorative Therapies, Inc., which could imply a lack of confidence or a strategic exit.

Positives

• NA

Negatives

• The reporting person, Todd Hale Morrison, now holds 0 shares, representing 0.0% of the outstanding common stock as of February 23, 2026.
• This indicates a complete divestment of shares by the reporting person, which, assuming previous filings showed ownership (implied by "Amendment No. 8"), signifies a negative change in investor holdings and could be interpreted as a lack of confidence.

Risks

• NA

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for passive investors. This particular filing indicates a complete divestment by Todd Hale Morrison, which could be a signal for the market regarding investor sentiment towards BioRestorative Therapies, Inc.

Stakeholder Impact

• Shareholders: The complete divestment by a reporting person could be perceived negatively, potentially impacting investor confidence and share price.

Key Dates

Recommendation

The complete divestment by Todd Hale Morrison, as indicated by the 0% beneficial ownership in this Amendment No. 8 filing, suggests a lack of confidence from a previous holder. While the filing itself doesn't provide reasons, a full exit by an investor is typically a bearish signal, prompting a "sell" recommendation for existing holders or a "avoid" for potential investors, as it implies a negative outlook from an informed party.

Keywords

BioRestorative Therapies, BRTX, Schedule 13G, Beneficial Ownership, Common Stock, Todd Hale Morrison, SEC Filing, Ownership Change